Health and Pharmaceuticals

Regis to be priced in top half of range

Current owners of the aged care provider, valued at around $1bn, may sell more shares than initially planned in the IPO.

Top Ramsay Health shareholder to sell 2.2% stake

Paul Ramsay Holdings will sell over 4 million shares in the hospital operator, worth around $224.4m, through a book build tonight.

Regis plans to double in size in 5 years

The aged care provider is meeting with fund managers as it prepares to raise at least $407m from an IPO on Monday.

Cabinet okays competitiveness agenda

Govt to support strongest parts of the economy, industry to back apprentice training.

Sigma H1 profit jumps 37%

Sigma Pharmaceuticals says market share rising, will boost H2 growth.

Regis listing will boost sector profile: Japara

The boss of the country’s only listed aged-care operator supports rival's IPO push.

DataRoom AM: Rinehart ambition

Gina Rinehart may still be mulling a play for Fairfax Media, while the sale of SAI Global is in doubt.

Sigma in $26m Discount Drugs buy

Sigma Pharmaceuticals' two recent acquisitions expected to add $400m in new revenue.

Osprey Medical mulls dual listing in the US

ASX-listed group will look to raise capital to hire a sales force at the end of 2015.

Data ‘encouraging’ for $4bn Medibank float

Medibank Private’s IPO given a boost by data on the private health industry.

Primary can do health insurance: Bateman

Chief executive says private health insurance is 'overpriced and poor value' amid Medibank Private jostle.

Medibank IPO to go ahead in 2014

The prospectus is to be lodged in late October, with a listing on the ASX expected in December, says Finance Minister Mathias Cormann.

Monash IVF in mood to buy

Strong results see firm flagging potential purchase of a major fertility services provider.

IVF babies boost profit for Monash

Pregnancy rates have underpinned success for the newly listed company.

Ramsay Health Care lifts FY profit

Health care provider sees profit continuing to improve ahead after posting a 14% rise.

Healthscope FY meets guidance

Biggest IPO of the last four years says it remains on track to meet prospectus guidance for FY15 earnings.

GP co-payment on track for Senate failure

by AAP
PUP senators vote against charge 'of even 1 cent'.

Blackmores posts modest FY profit lift

Vitamin and dietary supplement company sees instability in Thailand damaging sales.

Mesoblast widens FY loss

Biotech company falls further into the red but sees increased clinical development ahead.

NIB posts FY profit rise

Health insurer sees growth in year ahead, says Medibank float will increase competition.

Pages